Director Clinical Education and Clinical Support Lawrence, Massachusetts, United States
Disclosure(s):
Torsten Rinne, MD: No relevant disclosure to display
Background: Mechanical blood trauma remains a significant complication in extracorporeal membrane oxygenation (ECMO), and the pump design may be a contributor to hemolysis risks. This analysis aims to evaluate the impact of the Xenios DP3 blood pump, which typically has a higher rotational speed, on hemocompatibility and the risk of hemolysis.
Methods: This analysis combines a computational fluid dynamics (CFD)–based rotor evaluation, pump design comparisons, and a systematic literature review that covers high-level evidence on contemporary ECMO systems and DP3-related studies, including ELSO registry data. Studies comparing DP3-based systems with centrifugal pumps were analyzed for differences in plasma-free hemoglobin.
Outcome: CFD and design analyses demonstrated that, despite higher rotational speeds, the DP3 pump exhibits rotor tip speeds comparable to those of centrifugal pumps under equivalent flow conditions, attributable to its smaller rotor diameter. Key design features of the DP3 pump—including a low priming volume (16 mL), reduced blood residence time, lower recirculation ratios at low flows, and a single-point bearing with secondary washout flow—are expected to mitigate shear-related blood damage when compared to other pump designs. Clinical evidence (covering 18 studies and 1908 patients in total) reported hemolysis incidence of 0–16.7% in 630 patients treated with the DP3 pump, comparable to hemolysis rates of 0.6–32% reported in contemporary ECMO data. Importantly, direct comparative studies consistently showed no significant differences in plasma fHb levels between the DP3 and centrifugal pumps, despite the diagonal pump's higher operating RPM. Furthermore, real-time monitoring of pump drive power consumption enabled early detection of pump head thrombosis, a recognized mechanical cause of severe hemolysis.
Conclusion: Integrated engineering and clinical evidence indicate that rotational speed alone does not predict hemolysis risk in ECMO blood pumps. The diagonal DP3 pump achieves hemolysis rates comparable to centrifugal systems through optimized rotor geometry, reduced priming volume, and minimized recirculation. These findings underscore the holistic pump design in hemocompatibility assessment.
